Suppr超能文献

肾上腺“偶发瘤”中11β-羟化酶而非21-羟化酶的损伤

Impairment of 11 beta-hydroxylase but not 21-hydroxylase in adrenal 'incidentalomas'.

作者信息

Reincke M, Peter M, Sippell W G, Allolio B

机构信息

Medizinische Universitätsklinik Würzburg, Germany.

出版信息

Eur J Endocrinol. 1997 Feb;136(2):196-200. doi: 10.1530/eje.0.1360196.

Abstract

Recent reports have shown an exaggerated response of 17-hydroxyprogesterone in up to 70% of patients with incidentally detected adrenal adenomas ('incidentalomas'). This has been explained by pre-existing 21-hydroxylase deficiency which may be a pathogenetic factor in the development of adrenal tumours. However, other defects in steroidogenesis, such as mild 11 beta-hydroxylase deficiency, could also result in increased 17-hydroxyprogesterone secretion. We therefore studied the glucocorticoid and mineralocorticoid pathways in patients with adrenal 'incidentalomas' by measuring multiple adrenal steroids before and after 1-24 ACTH stimulation. Twenty patients with adrenal 'incidentalomas' (14 females, 6 males) and 27 healthy controls (14 females, 13 males) were studied. All subjects underwent a 1-24 ACTH stimulation test (250 micrograms i.v.) with determination of progesterone, 11-deoxycorticosterone, corticosterone, 17-hydroxyprogesterone, 11-deoxycortisol and cortisol at 0 and 60 min. All steroids were measured by RIA after extraction and HPLC. Patients with 'incidentalomas' had higher stimulated concentrations of 17-hydroxyprogesterone (21.6 +/- 8.4 vs 4.2 +/- 0.3 nmol/I; P < or = 0.001), 11-deoxycortisol (8.1 +/- 1.2 vs 3.6 +/- 0.3 nmol/I; P < or = 0.001), progesterone (8.28 +/- 2.82, vs 1.08 +/- 0.15 nmol/I; P < or = 0.001), and 11-deoxycorticosterone (2.1 +/- 0.39 vs 0.78 +/- 0.12 nmol/I; P = 0.002) compared with controls. In contrast, cortisol and corticosterone concentrations were not different. There was evidence for impairment of 11 beta-hydroxylase activity by an increased 11-deoxycortisol/ cortisol ratio (0.012 +/- 0.003 vs 0.005 +/- 0.001 in controls; P = 0.002) and 11-deoxycorticosterone/ corticosterone ratio (0.04 +/- 0.003 vs 0.015 +/- 0.003; P = 0.003). The conclusions reached were that patients with adrenal 'incidentalomas' have increased responses of precursors of the mineralocorticoid and glucocorticoid pathway including 17-hydroxyprogesterone after stimulation with ACTH. This seems to be caused by impairment of 11 beta-hydroxylase activity rather than by impaired 21-hydroxylase activity in these tumours.

摘要

最近的报告显示,在高达70%的偶然发现的肾上腺腺瘤(“偶发瘤”)患者中,17-羟孕酮反应过度。这可以用先前存在的21-羟化酶缺乏来解释,这可能是肾上腺肿瘤发生发展的一个致病因素。然而,类固醇生成中的其他缺陷,如轻度11β-羟化酶缺乏,也可能导致17-羟孕酮分泌增加。因此,我们通过测量1-24促肾上腺皮质激素(ACTH)刺激前后的多种肾上腺类固醇,研究了肾上腺“偶发瘤”患者的糖皮质激素和盐皮质激素途径。研究了20例肾上腺“偶发瘤”患者(14例女性,6例男性)和27例健康对照者(14例女性,13例男性)。所有受试者均接受了1-24 ACTH刺激试验(静脉注射250微克),并在0和60分钟时测定孕酮、11-脱氧皮质酮、皮质酮、17-羟孕酮、11-脱氧皮质醇和皮质醇。所有类固醇在提取和高效液相色谱(HPLC)后通过放射免疫分析(RIA)进行测量。与对照组相比,“偶发瘤”患者刺激后的17-羟孕酮(21.6±8.4对4.2±0.3 nmol/L;P≤0.001)、11-脱氧皮质醇(8.1±1.2对3.6±0.3 nmol/L;P≤0.001)、孕酮(8.28±2.82对1.08±0.15 nmol/L;P≤0.001)和11-脱氧皮质酮(2.1±0.39对0.78±0.12 nmol/L;P = 0.002)浓度更高。相比之下,皮质醇和皮质酮浓度没有差异。有证据表明,11β-羟化酶活性受损,表现为11-脱氧皮质醇/皮质醇比值增加(对照组为0.012±0.003对0.005±0.001;P = 0.002)和11-脱氧皮质酮/皮质酮比值增加(0.04±0.003对0.015±0.003;P = 0.003)。得出的结论是,肾上腺“偶发瘤”患者在ACTH刺激后,盐皮质激素和糖皮质激素途径的前体包括17-羟孕酮的反应增加。这似乎是由这些肿瘤中11β-羟化酶活性受损而非21-羟化酶活性受损引起的。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验